Article,
Formulation Development and in Vitro Evaluation of Capecitabine Immediate Release Tablets
INTERNATIONAL JOURNAL OF TREND IN SCIENTIFIC RESEARCH AND DEVELOPMENT, 7 (2): 566-574 (April 2023)
Abstract
The aim of this study is to formulate and significantly improve the bioavailability and reduce the side effects of immediate release tablets Capecitabine. The precompression blends of Capecitabine were characterized with respect to angle of repose bulk density tapped density Carr’s index and Hausner’s ratio. The precompression blend of all the batches indicates good to fair flowability and compressibility. Immediate release tablets were prepared with various disintegrants like PEG 6000 Croscarmellose sodium and Sodium starch glycolate at different concentration ratios and were compressed into tablets. The formulated tablets were evaluated for various quality control parameters. The tablets were passed all tests. Among all the formulations F7 formulation containing drug and Croscarmellose sodium showed good result that is 98.12 in 45 min. Hence from the dissolution data it was evident that F7 formulation is the better formulation. Dr. G. Jagadish | Dr. Vibhor Kumar Jain | Rama Shukla "Formulation Development and in Vitro Evaluation of Capecitabine Immediate Release Tablets" Published in International Journal of Trend in Scientific Research and Development (ijtsrd) ISSN: 2456-6470 Volume-7 | Issue-2 April 2023 URL: https://www.ijtsrd.com.com/papers/ijtsrd55058.pdf Paper URL: https://www.ijtsrd.com.com/pharmacy/pharmaceutics/55058/formulation-development-and-in-vitro-evaluation-of-capecitabine-immediate-release-tablets/dr-g-jagadish
